564 results on '"Brennan, Donal J"'
Search Results
2. Use of an aortic balloon to achieve uterine conservation in a case of placenta accreta spectrum: A case report.
3. Multidisciplinary Surgical Approach to Increase Survival for Advanced Ovarian Cancer in a Tertiary Gynaecological Oncology Centre
4. The feasibility and outcomes of metabolic and bariatric surgery prior to neoplastic therapy
5. Spatial proteomics and transcriptomics of the maternal-fetal interface in placenta accreta spectrum
6. Correction: Radiomics-based prediction of FIGO grade for placenta accreta spectrum
7. Radiomics-based prediction of FIGO grade for placenta accreta spectrum
8. Managing menopause after cancer
9. The Sleepio After Cancer (SAC) study. Digital cognitive behavioural therapy for insomnia (dCBT-I) in women cancer patients – Trial protocol of a randomised controlled trial
10. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland
11. Using menopausal hormone therapy after a cancer diagnosis in Ireland
12. Molecular Profiling Should be Done to Guide the Management of Endometrial Cancer?
13. Global variation and outcomes of expectant management of CSP
14. Complex caesarean delivery
15. Living beyond placenta accreta spectrum: parent’s experience of the postnatal journey and recommendations for an integrated care pathway
16. Maternal morbidity in placenta accreta spectrum following introduction of a multi-disciplinary service compared to standard care: an Irish perspective
17. The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study
18. Spatial proteomics and transcriptomics of placenta accreta spectrum
19. Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life—Results from the Menopause after Cancer (Mac) Study
20. The feasibility and outcomes of metabolic and bariatric surgery prior to neoplastic therapy
21. From physical to virtual: How the COVID-19 pandemic changed a tertiary gynaecologic oncology surveillance program in Ireland
22. The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer
23. The impact of accurately timed mid-luteal endometrial injury in nulligravid women undergoing their first or second embryo transfer
24. A life changing experience: An interpretative phenomenological analysis of women’s experiences of placenta accreta spectrum
25. Time to Evolve Terminology from “Debulking” to Cytoreductive Surgery (CRS) in Ovarian Cancer
26. Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: A metanalysis
27. Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer
28. The Impact of Sarcopenia and Low Muscle Attenuation on Overall Survival in Epithelial Ovarian Cancer: A Systematic Review and Meta-analysis
29. A meta-analysis of morbidity and mortality in primary cytoreductive surgery compared to neoadjuvant chemotherapy in advanced ovarian malignancy
30. Author Correction: Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
31. Anesthesia and postpartum pain management for placenta accreta spectrum: The patient perspective and recommendations for care.
32. Anesthesia and postpartum pain management for placenta accreta spectrum: The healthcare provider perspective.
33. Multidisciplinary Surgical Approach to Increase Survival for Advanced Ovarian Cancer in a Tertiary Gynaecological Oncology Centre
34. Anesthesia and postpartum pain management for placenta accreta spectrum: The healthcare provider perspective
35. Anesthesia and postpartum pain management for placenta accreta spectrum: The patient perspective and recommendations for care
36. Placenta accreta spectrum - the ongoing evolution of an iatrogenic condition
37. Supplementary Figures from Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma
38. Supplementary Tables from Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma
39. Data from Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma
40. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis
41. Small gene networks delineate immune cell states and characterize immunotherapy response in melanoma
42. Living with a diagnosis of Placenta Accreta Spectrum: Mothers’ and Fathers’ experience of the antenatal journey and the birth
43. Care after premenopausal risk‐reducing salpingo‐oophorectomy in high‐risk women: Scoping review and international consensus recommendations
44. Improving response to progestin treatment of low-grade endometrial cancer
45. Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer
46. Data from Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
47. Supplementary Methods, Figures 1-10, Tables 1-8 from Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
48. Supplementary Figure 3 from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro
49. Supplementary Figure Legend from miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro
50. Supplementary Tables 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.